Cancer Research  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 36, 2176-2181, July 1, 1976]
© 1976 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Primus, F. J.
Right arrow Articles by Goldenberg, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Primus, F. J.
Right arrow Articles by Goldenberg, D. M.

Antibody to Carcinoembryonic Antigen in Hamsters Bearing GW-39 Human Tumors1

F. James Primus2, Reenie H. Wang, Elias Cohen, Hans J. Hansen and David M. Goldenberg

Department of Immunology, Hoffmann-La Roche Inc., Nutley, New Jersey 07110 [F. J. P., R. H. W., H. J. H.] ; Department of Clinical Immunology, Roswell Park Memorial Institute, Buffalo, New York 14203 [E. C.]; and Department of Pathology, University of Kentucky Medical Center, Lexington, Kentucky 40506 [D. M. G.].

2 To whom requests for reprints should be addressed.

The appearance of anti-carcinoembryonic antigen (CEA) activity in the sera of hamsters bearing i.m. heterografts of GW-39, a CEA-producing colonic tumor of human origin, was demonstrated in radioimmunoassay using radioiodinated CEA purified from GW-39. Column chromatography, sucrose gradient ultracentrifugation, and radioimmunoelectrophoresis of pooled sera from tumor-bearing hamsters showed that the CEA antibody was of the immunoglobulin M type. The CEA antibody in tumor sera contained two specificities that reacted with different determinants on the CEA. One specificity reacted with a blood group-related determinant, whereas the remaining specificity was against a unique site on the CEA. Sequential analysis of individual tumor-bearing animals revealed that an increase in tumor growth paralleled the concomitant appearance of circulating CEA and highest antibody titer, suggesting that immunoglobulin M antibody, antigen, or complexes thereof influence tumor growth in this model.

1 This investigation was supported, in part, by USPHS Grant CA-15799 from the National Cancer Institute through the National Large Bowel Cancer Project.

Received 3/ 4/75. Accepted 3/17/76.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1976 by the American Association for Cancer Research.